ArticleJournal for immunotherapy of cancer2019

Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity.

Abhishek S Kashyap et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.